Literature DB >> 22036050

Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders.

Isaac-Jacques Kadoch1, Simon J Phillips, François Bissonnette.   

Abstract

The use of modified natural-cycle in vitro fertilization (IVF) is a valuable alternative to controlled ovarian hyperstimulation in young poor responders and should be considered in patients who require IVF and demonstrate endocrinologic evidence of ovarian aging and in those who have had one or two canceled controlled ovarian hyperstimulation cycles.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036050     DOI: 10.1016/j.fertnstert.2011.09.052

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Accumulation of oocytes from a few modified natural cycles to improve IVF results: a pilot study.

Authors:  Ermanno Greco; Katarzyna Litwicka; Cristiana Arrivi; Maria Teresa Varricchio; Daniela Zavaglia; Cecilia Mencacci; Maria Giulia Minasi
Journal:  J Assist Reprod Genet       Date:  2013-11       Impact factor: 3.412

2.  Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience.

Authors:  Talya Shaulov; Maria P Vélez; Karen Buzaglo; Simon J Phillips; Isaac Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2015-06-04       Impact factor: 3.412

Review 3.  Poor ovarian response and the possible role of natural and modified natural cycles.

Authors:  Federica Di Guardo; Christophe Blockeel; Michel De Vos; Marco Palumbo; Nikolaos Christoforidis; Herman Tournaye; Panagiotis Drakopoulos
Journal:  Ther Adv Reprod Health       Date:  2022-01-14

Review 4.  The Conundrum of Poor Ovarian Response: From Diagnosis to Treatment.

Authors:  Polina Giannelou; Mara Simopoulou; Sokratis Grigoriadis; Evangelos Makrakis; Adamantia Kontogeorgi; Agni Pantou; Dionysios Galatis; Theodoros Kalampokas; Panagiotis Bakas; Stamatis Bolaris; Konstantinos Pantos; Konstantinos Sfakianoudis
Journal:  Diagnostics (Basel)       Date:  2020-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.